Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - fexofenadine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - fexofenadine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - fexofenadine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

symbion pty ltd - fexofenadine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - fexofenadine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - fexofenadine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - fexofenadine hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - fexofenadine hydrochloride 180mg - film coated tablet - 180 mg - active: fexofenadine hydrochloride 180mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose e-5 opadry pink 00a94480 macrogol 6000 magnesium stearate mannitol   silicified microcrystalline cellulose - relief of symptoms associated with seasonal allergic rhinitis or urticaria in adults and children aged 12 years or older

New Zealand - English - Medsafe (Medicines Safety Authority)

medreich new zealand limited - fexofenadine hydrochloride 180mg;   - film coated tablet - 180 mg - active: fexofenadine hydrochloride 180mg   excipient: colloidal silicon dioxide croscarmellose sodium hypromellose e-5 opadry pink 00a94480 macrogol 6000 magnesium stearate mannitol   silicified microcrystalline cellulose - relief of symptoms associated with seasonal allergic rhinitis or urticaria in adults and children aged 12 years or older

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - fexofenadine hydrochloride, quantity: 6 mg/ml - oral liquid, suspension - excipient ingredients: xanthan gum; butyl hydroxybenzoate; propyl hydroxybenzoate; titanium dioxide; disodium edetate; purified water; monobasic sodium phosphate monohydrate; poloxamer; xylitol; propylene glycol; dibasic sodium phosphate heptahydrate; sucrose; flavour - relief of symptoms associated with seasonal allergic rhinitis and allergic rhinitis in adults and children from 2 years of age. relief of symptoms associated with urticaria in adults and children from 6 months of age.